146 related articles for article (PubMed ID: 7459267)
1. Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis.
Tsambaos D; Orfanos CE
Br J Dermatol; 1981 Jan; 104(1):37-45. PubMed ID: 7459267
[TBL] [Abstract][Full Text] [Related]
2. Etretinate therapy stimulates deposition of mucus-like material in epidermis of patients with psoriasis.
Ellis CN; Gold RC; Grekin RC; Anderson TF; Swanson NA; Voorhees JJ
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):699-704. PubMed ID: 7068978
[TBL] [Abstract][Full Text] [Related]
3. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
Lauharanta J
Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
[No Abstract] [Full Text] [Related]
4. Influence of retinoid Ro 10-9359 on cell-mediated immunity in vivo.
Fulton RA; Souteyrand P; Thivolet J
Dermatologica; 1982; 165(6):568-72. PubMed ID: 7169132
[TBL] [Abstract][Full Text] [Related]
5. Fine structure of the intercellular space of psoriatic epidermis during retinoid (RO 10-9359) and retinoid-PUVA treatment.
Kanerva L; Lauharanta J; Niemi KM; Lassus A
Acta Derm Venereol; 1981; 61(4):319-28. PubMed ID: 6173987
[TBL] [Abstract][Full Text] [Related]
6. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
Haftek M; Faure M; Schmitt D; Thivolet J
J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
[TBL] [Abstract][Full Text] [Related]
7. Light and electron microscopy of psoriatic skin before and during retinoid (Ro 10-9359) and retinoid-PUVA treatment.
Kanerva L; Lauharanta J; Niemi KM; Lassus A
J Cutan Pathol; 1982 Jun; 9(3):175-88. PubMed ID: 7130503
[TBL] [Abstract][Full Text] [Related]
8. Etretinate treatment for psoriasis inhibits epidermal ornithine decarboxylase.
Lowe NJ; Kaplan R; Breeding J
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):697-8. PubMed ID: 7068977
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
Mashkilleysson AL; Mashkilleysson NA
Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
[TBL] [Abstract][Full Text] [Related]
10. [Aromatic retinoid (Ro-10) in the treatment of palmoplantar psoriasis pustulosa (author's transl)].
Deichmann B; Spindeldreier A
Z Hautkr; 1982 Mar; 57(6):425-8. PubMed ID: 7080591
[No Abstract] [Full Text] [Related]
11. Keratin polypeptide profile in psoriatic epidermis normalized by treatment with etretinate (aromatic retinoid Ro 10-9359).
Staquet MJ; Faure MR; Reano A; Viac J; Thivolet J
Arch Dermatol Res; 1983; 275(2):124-9. PubMed ID: 6191725
[TBL] [Abstract][Full Text] [Related]
12. [Granulocyte migration in vitro in psoriasis patients induced by aromatic retinoid].
Bauer R; Schütz R; Orfanos CE
Z Hautkr; 1982 Sep; 57(17):1247-54. PubMed ID: 7148057
[TBL] [Abstract][Full Text] [Related]
13. Ro 10-9359, an aromatic retinoid in the treatment of psoriatic arthritis. Clinical and immunological studies.
Rosenthal M
Arzneimittelforschung; 1982; 32(8):842-4. PubMed ID: 6890362
[TBL] [Abstract][Full Text] [Related]
14. Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.
Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Jul; 26(1):9-43. PubMed ID: 6224672
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of a new retinoid, Ro 12-7554, in psoriasis and in some congenital disorders of keratinization.
Ott F; Bounameaux Y
Dermatologica; 1983; 167(1):52-3. PubMed ID: 6226548
[TBL] [Abstract][Full Text] [Related]
16. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructure of pityriasis rubra pilaris with observations during retinoid (etretinate) treatment.
Kanerva L; Lauharanta J; Niemi KM; Lassus A
Br J Dermatol; 1983 Jun; 108(6):653-63. PubMed ID: 6190496
[TBL] [Abstract][Full Text] [Related]
18. [Erythema anulare centrifugum with pustulation. Successful oral retinoid therapy].
Stadler R; Orfanos CE
Hautarzt; 1981 Nov; 32(11):564-6. PubMed ID: 7309509
[TBL] [Abstract][Full Text] [Related]
19. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
Thivolet J; Robart S; Vignon E
Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
[TBL] [Abstract][Full Text] [Related]
20. Severe disorders of keratinization: effects of treatment with Tigason (etretinate).
Marks R; Finlay AY; Holt PJ
Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
